10X GENOMICS (Germany) Market Value
| 1KJ Stock | EUR 14.19 0.04 0.28% |
| Symbol | 10X |
10X GENOMICS 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to 10X GENOMICS's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of 10X GENOMICS.
| 11/06/2023 |
| 11/30/2024 |
If you would invest 0.00 in 10X GENOMICS on November 6, 2023 and sell it all today you would earn a total of 0.00 from holding 10X GENOMICS DL or generate 0.0% return on investment in 10X GENOMICS over 390 days. 10X GENOMICS is related to or competes with VIRGIN WINES, Ryanair Holdings, EAT WELL, DIVERSIFIED ROYALTY, and PennantPark Investment. 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for ana... More
10X GENOMICS Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure 10X GENOMICS's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess 10X GENOMICS DL upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 31.23 | |||
| Value At Risk | (7.78) | |||
| Potential Upside | 8.01 |
10X GENOMICS Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for 10X GENOMICS's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as 10X GENOMICS's standard deviation. In reality, there are many statistical measures that can use 10X GENOMICS historical prices to predict the future 10X GENOMICS's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (1.29) | |||
| Treynor Ratio | 0.6118 |
10X GENOMICS DL Backtested Returns
10X GENOMICS DL secures Sharpe Ratio (or Efficiency) of -0.0795, which signifies that the company had a -0.0795% return per unit of risk over the last 3 months. 10X GENOMICS DL exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm 10X GENOMICS's mean deviation of 3.64, and Variance of 28.35 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.66, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning 10X GENOMICS are expected to decrease at a much lower rate. During the bear market, 10X GENOMICS is likely to outperform the market. At this point, 10X GENOMICS DL has a negative expected return of -0.42%. Please make sure to confirm 10X GENOMICS's total risk alpha, maximum drawdown, skewness, as well as the relationship between the treynor ratio and potential upside , to decide if 10X GENOMICS DL performance from the past will be repeated sooner or later.
Auto-correlation | 0.46 |
Average predictability
10X GENOMICS DL has average predictability. Overlapping area represents the amount of predictability between 10X GENOMICS time series from 6th of November 2023 to 19th of May 2024 and 19th of May 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of 10X GENOMICS DL price movement. The serial correlation of 0.46 indicates that about 46.0% of current 10X GENOMICS price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.46 | |
| Spearman Rank Test | 0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 6.48 |
10X GENOMICS DL lagged returns against current returns
Autocorrelation, which is 10X GENOMICS stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting 10X GENOMICS's stock expected returns. We can calculate the autocorrelation of 10X GENOMICS returns to help us make a trade decision. For example, suppose you find that 10X GENOMICS has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
10X GENOMICS regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If 10X GENOMICS stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if 10X GENOMICS stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in 10X GENOMICS stock over time.
Current vs Lagged Prices |
| Timeline |
10X GENOMICS Lagged Returns
When evaluating 10X GENOMICS's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of 10X GENOMICS stock have on its future price. 10X GENOMICS autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, 10X GENOMICS autocorrelation shows the relationship between 10X GENOMICS stock current value and its past values and can show if there is a momentum factor associated with investing in 10X GENOMICS DL.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in 10X Stock
10X GENOMICS financial ratios help investors to determine whether 10X Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 10X with respect to the benefits of owning 10X GENOMICS security.